| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | scaffold protein binding | 7.27e-06 | 93 | 100 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.95e-05 | 11 | 100 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 3.36e-05 | 13 | 100 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 7.42e-05 | 3 | 100 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.42e-05 | 18 | 100 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.47e-04 | 100 | 100 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.65e-04 | 28 | 100 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 5.44e-04 | 32 | 100 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.37e-04 | 37 | 100 | 3 | GO:0045505 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.96e-07 | 130 | 98 | 8 | GO:0060079 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 5.03e-07 | 147 | 98 | 8 | GO:0099565 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.32e-06 | 180 | 98 | 8 | GO:0060078 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | MPP2 CACNA1A CHRNA6 GRIK2 MECP2 SHANK3 CHRNB1 KCNH4 ADORA1 PTPN3 MTOR DLG4 CACNA1G | 2.42e-06 | 559 | 98 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | neuromuscular process | 1.20e-05 | 225 | 98 | 8 | GO:0050905 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 1.93e-05 | 69 | 98 | 5 | GO:0050881 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1A HTR6 HIPK2 GRIK2 KAT2A FIGN PIAS1 MECP2 SHANK3 CHRNB1 ADORA1 KAT2B MTOR DLG4 TACR3 | 1.94e-05 | 891 | 98 | 15 | GO:0007610 |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 2.54e-05 | 73 | 98 | 5 | GO:0050879 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 3.35e-05 | 128 | 98 | 6 | GO:0050795 | |
| GeneOntologyBiologicalProcess | positive regulation of urine volume | 4.54e-05 | 15 | 98 | 3 | GO:0035810 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 5.62e-05 | 44 | 98 | 4 | GO:0007271 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 7.85e-05 | 293 | 98 | 8 | GO:0048167 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 1.24e-04 | 233 | 98 | 7 | GO:0050806 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | MPP2 CACNA1A CHRNA6 HTR4 HTR6 GRIK2 KAT2A MECP2 SHANK3 CHRNB1 ADORA1 MTOR DLG4 CACNA1G | 1.26e-04 | 931 | 98 | 14 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | MPP2 CACNA1A CHRNA6 HTR4 HTR6 GRIK2 KAT2A MECP2 SHANK3 CHRNB1 ADORA1 MTOR DLG4 CACNA1G | 1.26e-04 | 931 | 98 | 14 | GO:0007268 |
| GeneOntologyBiologicalProcess | calcineurin-NFAT signaling cascade | 1.26e-04 | 54 | 98 | 4 | GO:0033173 | |
| GeneOntologyBiologicalProcess | L-histidine catabolic process to glutamate and formate | 1.33e-04 | 4 | 98 | 2 | GO:0019557 | |
| GeneOntologyBiologicalProcess | L-histidine catabolic process to glutamate and formamide | 1.33e-04 | 4 | 98 | 2 | GO:0019556 | |
| GeneOntologyBiologicalProcess | formamide metabolic process | 1.33e-04 | 4 | 98 | 2 | GO:0043606 | |
| GeneOntologyBiologicalProcess | positive regulation of renal sodium excretion | 1.33e-04 | 4 | 98 | 2 | GO:0035815 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | MPP2 CACNA1A CHRNA6 HTR4 HTR6 GRIK2 KAT2A MECP2 SHANK3 CHRNB1 ADORA1 MTOR DLG4 CACNA1G | 1.38e-04 | 939 | 98 | 14 | GO:0099537 |
| GeneOntologyBiologicalProcess | calcineurin-mediated signaling | 1.67e-04 | 58 | 98 | 4 | GO:0097720 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.67e-04 | 327 | 98 | 8 | GO:0048738 | |
| GeneOntologyBiologicalProcess | cognition | 1.85e-04 | 423 | 98 | 9 | GO:0050890 | |
| GeneOntologyBiologicalProcess | regulation of system process | NPPB NPR1 GRIK2 GTF2IRD1 MECP2 SHANK3 ADORA1 MTOR DLG4 CACNA1G TACR3 ATP2A1 | 1.86e-04 | 734 | 98 | 12 | GO:0044057 |
| GeneOntologyBiologicalProcess | synaptic signaling | MPP2 CACNA1A CHRNA6 HTR4 HTR6 GRIK2 KAT2A MECP2 SHANK3 CHRNB1 ADORA1 MTOR DLG4 CACNA1G | 2.06e-04 | 976 | 98 | 14 | GO:0099536 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 2.60e-04 | 349 | 98 | 8 | GO:0014706 | |
| GeneOntologyBiologicalProcess | body fluid secretion | 2.81e-04 | 121 | 98 | 5 | GO:0007589 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.81e-04 | 121 | 98 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | MPP2 CACNA1A CHRNA6 HTR6 GRIK2 KAT2A MECP2 SHANK3 ADORA1 MTOR DLG4 | 3.09e-04 | 663 | 98 | 11 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of renal system process | 3.13e-04 | 28 | 98 | 3 | GO:0098801 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | MPP2 CACNA1A CHRNA6 HTR6 GRIK2 KAT2A MECP2 SHANK3 ADORA1 MTOR DLG4 | 3.13e-04 | 664 | 98 | 11 | GO:0099177 |
| GeneOntologyBiologicalProcess | formate metabolic process | 3.31e-04 | 6 | 98 | 2 | GO:0015942 | |
| GeneOntologyBiologicalProcess | regulation of grooming behavior | 3.31e-04 | 6 | 98 | 2 | GO:2000821 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 3.39e-04 | 126 | 98 | 5 | GO:0033555 | |
| GeneOntologyBiologicalProcess | response to cocaine | 3.65e-04 | 71 | 98 | 4 | GO:0042220 | |
| GeneOntologyBiologicalProcess | regulation of urine volume | 3.85e-04 | 30 | 98 | 3 | GO:0035809 | |
| GeneOntologyBiologicalProcess | learning or memory | 4.05e-04 | 373 | 98 | 8 | GO:0007611 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 4.14e-04 | 284 | 98 | 7 | GO:0007626 | |
| GeneOntologyBiologicalProcess | social behavior | 4.27e-04 | 74 | 98 | 4 | GO:0035176 | |
| GeneOntologyBiologicalProcess | regulation of acetylcholine secretion, neurotransmission | 4.62e-04 | 7 | 98 | 2 | GO:0014056 | |
| GeneOntologyBiologicalProcess | acetylcholine secretion, neurotransmission | 4.62e-04 | 7 | 98 | 2 | GO:0014055 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 4.73e-04 | 76 | 98 | 4 | GO:0051703 | |
| GeneOntologyBiologicalProcess | learning | 5.27e-04 | 212 | 98 | 6 | GO:0007612 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 5.59e-04 | 34 | 98 | 3 | GO:0090311 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 5.75e-04 | 80 | 98 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | negative regulation of centriole replication | 6.14e-04 | 8 | 98 | 2 | GO:0046600 | |
| GeneOntologyBiologicalProcess | acetylcholine secretion | 6.14e-04 | 8 | 98 | 2 | GO:0061526 | |
| GeneOntologyBiologicalProcess | regulation of cholangiocyte proliferation | 6.14e-04 | 8 | 98 | 2 | GO:1904054 | |
| GeneOntologyBiologicalProcess | L-histidine catabolic process | 6.14e-04 | 8 | 98 | 2 | GO:0006548 | |
| GeneOntologyBiologicalProcess | regulation of renal sodium excretion | 6.14e-04 | 8 | 98 | 2 | GO:0035813 | |
| GeneOntologyBiologicalProcess | imidazole-containing compound catabolic process | 6.14e-04 | 8 | 98 | 2 | GO:0052805 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 6.24e-04 | 144 | 98 | 5 | GO:0060291 | |
| GeneOntologyBiologicalProcess | receptor clustering | 6.61e-04 | 83 | 98 | 4 | GO:0043113 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 7.78e-04 | 38 | 98 | 3 | GO:0050951 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A CHRNA6 SLC38A5 COX15 GRIK2 SHANK3 CHRNB1 KCNH4 PTPN3 MTOR TRPM8 CACNA1G PLCG2 ATP2A1 | 7.81e-04 | 1115 | 98 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | voluntary musculoskeletal movement | 7.87e-04 | 9 | 98 | 2 | GO:0050882 | |
| GeneOntologyBiologicalProcess | positive regulation of cGMP-mediated signaling | 7.87e-04 | 9 | 98 | 2 | GO:0010753 | |
| GeneOntologyBiologicalProcess | negative regulation of glutamate secretion | 7.87e-04 | 9 | 98 | 2 | GO:0014050 | |
| GeneOntologyBiologicalProcess | thermoception | 7.87e-04 | 9 | 98 | 2 | GO:0050955 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 8.95e-04 | 421 | 98 | 8 | GO:0010639 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 9.05e-04 | 40 | 98 | 3 | GO:0048169 | |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 9.73e-04 | 41 | 98 | 3 | GO:0070286 | |
| GeneOntologyBiologicalProcess | regulation of AMPA glutamate receptor clustering | 9.81e-04 | 10 | 98 | 2 | GO:1904717 | |
| GeneOntologyBiologicalProcess | regulation of glutamate receptor clustering | 9.81e-04 | 10 | 98 | 2 | GO:0106104 | |
| GeneOntologyBiologicalProcess | L-histidine metabolic process | 9.81e-04 | 10 | 98 | 2 | GO:0006547 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 9.81e-04 | 10 | 98 | 2 | GO:1990705 | |
| GeneOntologyBiologicalProcess | respiratory gaseous exchange by respiratory system | 1.01e-03 | 93 | 98 | 4 | GO:0007585 | |
| GeneOntologyBiologicalProcess | muscle system process | NPPB DYRK1A GTF2IRD1 CHRNB1 ADORA1 MTOR CACNA1G TACR3 ATP2A1 | 1.18e-03 | 547 | 98 | 9 | GO:0003012 |
| GeneOntologyBiologicalProcess | circadian rhythm | 1.19e-03 | 248 | 98 | 6 | GO:0007623 | |
| GeneOntologyBiologicalProcess | regulation of calcineurin-NFAT signaling cascade | 1.20e-03 | 44 | 98 | 3 | GO:0070884 | |
| GeneOntologyBiologicalProcess | regulation of calcineurin-mediated signaling | 1.28e-03 | 45 | 98 | 3 | GO:0106056 | |
| GeneOntologyCellularComponent | synaptic membrane | MPP2 CACNA1A CHRNA6 ERBB3 GRIK2 SHANK3 CHRNB1 ADORA1 MPP4 ITSN2 DLG4 | 9.90e-05 | 583 | 99 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.31e-04 | 405 | 99 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.20e-04 | 25 | 99 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.34e-04 | 378 | 99 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | leading edge membrane | 4.93e-04 | 210 | 99 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | sperm flagellum | 5.45e-04 | 214 | 99 | 6 | GO:0036126 | |
| GeneOntologyCellularComponent | dendrite | MPP2 CACNA1A HTR4 HTR6 DYRK1A GRIK2 SHANK3 ADORA1 MTOR DLG4 CACNA1G TACR3 | 7.37e-04 | 858 | 99 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MPP2 CACNA1A HTR4 HTR6 DYRK1A GRIK2 SHANK3 ADORA1 MTOR DLG4 CACNA1G TACR3 | 7.52e-04 | 860 | 99 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A CHRNA6 GRIK2 CHRNB1 KCNH4 DLG4 CACNA1G UQCR11 ATP2A1 | 8.45e-04 | 523 | 99 | 9 | GO:1902495 |
| GeneOntologyCellularComponent | cation channel complex | 8.88e-04 | 235 | 99 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 9.49e-04 | 238 | 99 | 6 | GO:0097729 | |
| GeneOntologyCellularComponent | inner dynein arm | 9.75e-04 | 10 | 99 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | postsynapse | MPP2 CACNA1A CHRNA6 ERBB3 HTR4 GRIK2 PIAS1 MECP2 SHANK3 CHRNB1 ADORA1 MTOR DLG4 | 1.02e-03 | 1018 | 99 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | transporter complex | CACNA1A CHRNA6 GRIK2 CHRNB1 KCNH4 DLG4 CACNA1G UQCR11 ATP2A1 | 1.20e-03 | 550 | 99 | 9 | GO:1990351 |
| GeneOntologyCellularComponent | ATAC complex | 1.95e-03 | 14 | 99 | 2 | GO:0140672 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.05e-03 | 277 | 99 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | dynein complex | 2.15e-03 | 54 | 99 | 3 | GO:0030286 | |
| HumanPheno | Tongue thrusting | 4.17e-06 | 17 | 35 | 4 | HP:0100703 | |
| HumanPheno | Resting tremor | 4.74e-05 | 60 | 35 | 5 | HP:0002322 | |
| HumanPheno | Inappropriate laughter | 6.64e-05 | 33 | 35 | 4 | HP:0000748 | |
| HumanPheno | Movement abnormality of the tongue | 6.64e-05 | 33 | 35 | 4 | HP:0000182 | |
| MousePheno | abnormal parental behavior | 4.71e-06 | 160 | 83 | 8 | MP:0002068 | |
| MousePheno | abnormal behavioral response to xenobiotic | CACNA1A HTR4 HTR6 SZT2 HIPK2 GRIK2 MECP2 SHANK3 DLG4 CACNA1G | 1.41e-05 | 309 | 83 | 10 | MP:0009745 |
| MousePheno | abnormal seizure response to inducing agent | 2.49e-05 | 201 | 83 | 8 | MP:0009357 | |
| MousePheno | abnormal seizure response to pharmacological agent | 2.62e-05 | 147 | 83 | 7 | MP:0000950 | |
| MousePheno | abnormal thermal nociception | 6.16e-05 | 168 | 83 | 7 | MP:0002733 | |
| MousePheno | abnormal fear-related response | 7.63e-05 | 74 | 83 | 5 | MP:0003106 | |
| MousePheno | increased anxiety-related response | HTR4 GTF2IRD1 MECP2 SHANK3 GATAD2B TXNDC11 ADORA1 DLG4 MOV10 | 9.22e-05 | 311 | 83 | 9 | MP:0001363 |
| MousePheno | abnormal stride length | 1.25e-04 | 82 | 83 | 5 | MP:0012690 | |
| MousePheno | abnormal pain threshold | 1.82e-04 | 267 | 83 | 8 | MP:0001970 | |
| Domain | PCAF_N | 2.73e-05 | 2 | 98 | 2 | IPR009464 | |
| Domain | TBP_CS | 2.73e-05 | 2 | 98 | 2 | IPR030491 | |
| Domain | TBP_eukaryotic | 2.73e-05 | 2 | 98 | 2 | IPR033710 | |
| Domain | Hist_acetylase_PCAF | 2.73e-05 | 2 | 98 | 2 | IPR016376 | |
| Domain | PCAF_N | 2.73e-05 | 2 | 98 | 2 | PF06466 | |
| Domain | Guanylate_kinase_CS | 7.47e-05 | 16 | 98 | 3 | IPR020590 | |
| Domain | TFIID | 8.15e-05 | 3 | 98 | 2 | PS00351 | |
| Domain | TBP | 8.15e-05 | 3 | 98 | 2 | PF00352 | |
| Domain | TBP | 8.15e-05 | 3 | 98 | 2 | IPR000814 | |
| Domain | GUANYLATE_KINASE_2 | 2.30e-04 | 23 | 98 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 2.30e-04 | 23 | 98 | 3 | PS00856 | |
| Domain | Guanylate_kin | 3.34e-04 | 26 | 98 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 3.34e-04 | 26 | 98 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 3.34e-04 | 26 | 98 | 3 | IPR008144 | |
| Domain | GuKc | 3.34e-04 | 26 | 98 | 3 | SM00072 | |
| Domain | Beta2_adaptin/TBP_C_dom | 4.03e-04 | 6 | 98 | 2 | IPR012295 | |
| Domain | - | 4.03e-04 | 6 | 98 | 2 | 3.30.310.10 | |
| Domain | PDZ | 8.84e-04 | 141 | 98 | 5 | PF00595 | |
| Domain | SH3 | 9.71e-04 | 216 | 98 | 6 | SM00326 | |
| Domain | SH3 | 9.71e-04 | 216 | 98 | 6 | PS50002 | |
| Domain | SH3_domain | 1.07e-03 | 220 | 98 | 6 | IPR001452 | |
| Domain | SH3_2 | 1.09e-03 | 86 | 98 | 4 | IPR011511 | |
| Domain | SH3_2 | 1.09e-03 | 86 | 98 | 4 | PF07653 | |
| Domain | PDZ | 1.10e-03 | 148 | 98 | 5 | SM00228 | |
| Domain | - | 1.17e-03 | 150 | 98 | 5 | 2.30.42.10 | |
| Domain | L27_C | 1.19e-03 | 10 | 98 | 2 | IPR014775 | |
| Domain | L27 | 1.19e-03 | 10 | 98 | 2 | PF02828 | |
| Domain | VDCCAlpha1 | 1.19e-03 | 10 | 98 | 2 | IPR002077 | |
| Domain | PDZ | 1.20e-03 | 151 | 98 | 5 | PS50106 | |
| Domain | PDZ | 1.24e-03 | 152 | 98 | 5 | IPR001478 | |
| Domain | L27 | 2.05e-03 | 13 | 98 | 2 | SM00569 | |
| Domain | L27 | 2.05e-03 | 13 | 98 | 2 | PS51022 | |
| Domain | L27_dom | 2.05e-03 | 13 | 98 | 2 | IPR004172 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.38e-03 | 14 | 98 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.38e-03 | 14 | 98 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.38e-03 | 14 | 98 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.38e-03 | 14 | 98 | 2 | PF08393 | |
| Domain | MT | 2.38e-03 | 14 | 98 | 2 | PF12777 | |
| Domain | AAA_8 | 2.38e-03 | 14 | 98 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.38e-03 | 14 | 98 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.38e-03 | 14 | 98 | 2 | PF07728 | |
| Domain | DHC_fam | 2.74e-03 | 15 | 98 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.74e-03 | 15 | 98 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.74e-03 | 15 | 98 | 2 | PF03028 | |
| Domain | Ion_trans_dom | 3.06e-03 | 114 | 98 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.06e-03 | 114 | 98 | 4 | PF00520 | |
| Domain | Nicotinic_acetylcholine_rcpt | 3.12e-03 | 16 | 98 | 2 | IPR002394 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.10e-06 | 178 | 78 | 8 | M2890 | |
| Pathway | REACTOME_PHYSIOLOGICAL_FACTORS | 5.68e-05 | 14 | 78 | 3 | M27459 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION | 1.29e-04 | 47 | 78 | 4 | M1095 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 27346147 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 10022868 | ||
| Pubmed | 1.32e-06 | 8 | 101 | 3 | 30319350 | ||
| Pubmed | 2.82e-06 | 300 | 101 | 8 | 19086053 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15502373 | ||
| Pubmed | Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance. | 8.35e-06 | 2 | 101 | 2 | 20034689 | |
| Pubmed | [5-HT6 receptor-mTOR: An hyperactive couple in neuropathic pain]. | 8.35e-06 | 2 | 101 | 2 | 34003104 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11027331 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15709752 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 34270849 | ||
| Pubmed | B-type natriuretic peptide decreases gastric emptying and absorption. | 8.35e-06 | 2 | 101 | 2 | 18367637 | |
| Pubmed | A friend within the heart: natriuretic peptide receptor signaling. | 8.35e-06 | 2 | 101 | 2 | 12727915 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 14737067 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25269644 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28678170 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19820693 | ||
| Pubmed | Identification of two novel Shank3 transcripts in the developing mouse neocortex. | 8.35e-06 | 2 | 101 | 2 | 24164323 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 37259855 | ||
| Pubmed | Influenza A virus nucleoprotein is acetylated by histone acetyltransferases PCAF and GCN5. | 8.35e-06 | 2 | 101 | 2 | 29555684 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 39304735 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 14960748 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11276111 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20547676 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19487812 | ||
| Pubmed | Localization of the human B-type natriuretic peptide precursor (NPPB) gene to chromosome 1p36. | 8.35e-06 | 2 | 101 | 2 | 7601467 | |
| Pubmed | 5-HT6 Receptor Recruitment of mTOR Modulates Seizure Activity in Epilepsy. | 8.35e-06 | 2 | 101 | 2 | 25034463 | |
| Pubmed | 8.45e-06 | 14 | 101 | 3 | 9373155 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | NPPB NPR1 CCT3 SZT2 HECTD3 OPN3 BCAS2 MRPL55 EFCAB2 GATAD2B MTOR MOV10 ZMYND12 | 9.28e-06 | 1031 | 101 | 13 | 16710414 |
| Pubmed | MPP2 CACNA1A CCT3 TCOF1 DYRK1A GRIK2 HUWE1 SHANK3 GATAD2B PPP2R5D MTOR DLG4 | 2.36e-05 | 963 | 101 | 12 | 28671696 | |
| Pubmed | Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. | 2.50e-05 | 3 | 101 | 2 | 21212100 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 26515065 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 15939815 | ||
| Pubmed | TBP/TFIID-dependent activation of MyoD target genes in skeletal muscle cells. | 2.50e-05 | 3 | 101 | 2 | 26880551 | |
| Pubmed | Characterization of binding sites in rat for A, B and C-type natriuretic peptides. | 2.50e-05 | 3 | 101 | 2 | 7901875 | |
| Pubmed | Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients. | 2.50e-05 | 3 | 101 | 2 | 29233126 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 35714614 | ||
| Pubmed | Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication. | 2.50e-05 | 3 | 101 | 2 | 11956210 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19346456 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 18250157 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16754798 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 27796307 | ||
| Pubmed | Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development. | 2.50e-05 | 3 | 101 | 2 | 29174768 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16875975 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 12124219 | ||
| Pubmed | miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes. | 2.50e-05 | 3 | 101 | 2 | 26344767 | |
| Pubmed | GCN5 inhibits XBP-1S-mediated transcription by antagonizing PCAF action. | 2.50e-05 | 3 | 101 | 2 | 25426559 | |
| Pubmed | Mpp4 recruits Psd95 and Veli3 towards the photoreceptor synapse. | 2.50e-05 | 3 | 101 | 2 | 16520334 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 33482199 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 12374802 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 24717731 | ||
| Pubmed | In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5. | 2.50e-05 | 3 | 101 | 2 | 33894414 | |
| Pubmed | HELZ2 promotes K63-linked polyubiquitination of c-Myc to induce retinoblastoma tumorigenesis. | 2.50e-05 | 3 | 101 | 2 | 34761308 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 33375031 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 4.46e-05 | 67 | 101 | 4 | 16987237 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 31800012 | ||
| Pubmed | Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. | 4.99e-05 | 4 | 101 | 2 | 14612453 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11279111 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 27941951 | ||
| Pubmed | Ubiquitination and inhibition of glycine receptor by HUWE1 in spinal cord dorsal horn. | 4.99e-05 | 4 | 101 | 2 | 30721695 | |
| Pubmed | PSD95beta regulates plasma membrane Ca2+ pump localization at the photoreceptor synapse. | 4.99e-05 | 4 | 101 | 2 | 19233278 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11304541 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 7656980 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 37934199 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 18430026 | ||
| Pubmed | Sensory integration in mouse insular cortex reflects GABA circuit maturation. | 4.99e-05 | 4 | 101 | 2 | 25088363 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 33273014 | ||
| Pubmed | Role of the alpha1G T-type calcium channel in spontaneous absence seizures in mutant mice. | 4.99e-05 | 4 | 101 | 2 | 15175395 | |
| Pubmed | Stride-level analysis of mouse open field behavior using deep-learning-based pose estimation. | 4.99e-05 | 4 | 101 | 2 | 35021077 | |
| Pubmed | A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers. | 4.99e-05 | 4 | 101 | 2 | 26438156 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 17301242 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 27307198 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 4.99e-05 | 4 | 101 | 2 | 21788606 | |
| Pubmed | Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. | 4.99e-05 | 4 | 101 | 2 | 34785661 | |
| Pubmed | The transcriptional co-activator PCAF regulates cdk2 activity. | 4.99e-05 | 4 | 101 | 2 | 19773423 | |
| Pubmed | P/CAF and GCN5 acetylate the AML1/MDS1/EVI1 fusion oncoprotein. | 4.99e-05 | 4 | 101 | 2 | 12878208 | |
| Pubmed | The PDZ1 domain of SAP90. Characterization of structure and binding. | 4.99e-05 | 4 | 101 | 2 | 11744724 | |
| Pubmed | A specific E3 ligase/deubiquitinase pair modulates TBP protein levels during muscle differentiation. | 4.99e-05 | 4 | 101 | 2 | 26393420 | |
| Pubmed | mTORC1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux. | 5.22e-05 | 25 | 101 | 3 | 30340022 | |
| Pubmed | ERBB3 DNAH2 HIPK2 KAT2A PTPRU PIAS1 KCNH4 KAT2B DNAH17 MMP15 | 5.39e-05 | 730 | 101 | 10 | 34857952 | |
| Pubmed | 6.61e-05 | 27 | 101 | 3 | 18838386 | ||
| Pubmed | NPPB TCOF1 BCAS2 VPS13C DNAH2 RNF17 XPO5 CACNA1G PLCG2 MOV10 | 7.04e-05 | 754 | 101 | 10 | 35906200 | |
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 7.39e-05 | 28 | 101 | 3 | 31600191 | |
| Pubmed | Gcn5 and PCAF regulate PPARγ and Prdm16 expression to facilitate brown adipogenesis. | 8.30e-05 | 5 | 101 | 2 | 25071153 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 21131905 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 20940704 | ||
| Pubmed | Cerebellar associative sensory learning defects in five mouse autism models. | 8.30e-05 | 5 | 101 | 2 | 26158416 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 33840455 | ||
| Pubmed | SAP90 binds and clusters kainate receptors causing incomplete desensitization. | 8.30e-05 | 5 | 101 | 2 | 9808460 | |
| Pubmed | Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. | 8.30e-05 | 5 | 101 | 2 | 16098514 | |
| Pubmed | Regulation of insulin gene transcription by multiple histone acetyltransferases. | 8.30e-05 | 5 | 101 | 2 | 21774670 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 16606358 | ||
| Pubmed | Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease. | 8.30e-05 | 5 | 101 | 2 | 16847693 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 10747963 | ||
| Pubmed | Identification and mapping of human histone acetylation modifier gene homologues. | 8.30e-05 | 5 | 101 | 2 | 9722949 | |
| Pubmed | Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation. | 8.30e-05 | 5 | 101 | 2 | 16582966 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 16412700 | ||
| Pubmed | Acetyltransferases GCN5 and PCAF Are Required for B Lymphocyte Maturation in Mice. | 8.30e-05 | 5 | 101 | 2 | 35053209 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 18089809 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 18834332 | ||
| Pubmed | TCOF1 HECTD3 BCAS2 KAT2A MECP2 GATAD2B KAT2B SUGP2 PNMA2 DLG4 EVI5L TBP | 9.70e-05 | 1116 | 101 | 12 | 31753913 | |
| Cytoband | 1p13.2 | 1.46e-04 | 46 | 101 | 3 | 1p13.2 | |
| Cytoband | 1p36.2 | 3.68e-04 | 13 | 101 | 2 | 1p36.2 | |
| GeneFamily | Dyneins, axonemal | 3.05e-05 | 17 | 66 | 3 | 536 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.14e-04 | 26 | 66 | 3 | 904 | |
| GeneFamily | PDZ domain containing | 2.33e-04 | 152 | 66 | 5 | 1220 | |
| GeneFamily | UPF1 like RNA helicases | 7.07e-04 | 11 | 66 | 2 | 1169 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 9.97e-04 | 13 | 66 | 2 | 170 | |
| GeneFamily | ATAC complex | 9.97e-04 | 13 | 66 | 2 | 1058 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.52e-03 | 16 | 66 | 2 | 173 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 1.72e-03 | 17 | 66 | 2 | 1059 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.72e-03 | 17 | 66 | 2 | 486 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.80e-03 | 66 | 66 | 3 | 722 | |
| GeneFamily | GCN5 related N-acetyltransferases | 3.44e-03 | 24 | 66 | 2 | 1134 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.03e-03 | 26 | 66 | 2 | 253 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | CACNA1A CHRNA6 NPR1 ERBB3 HTR4 DOCK8 DNAH2 DYRK1A IRF2 PTPRU MECP2 CHRNB1 DNAH1 PTPN3 FGD4 PLCG2 TBP | 5.75e-06 | 1281 | 99 | 17 | M1884 |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.47e-06 | 55 | 101 | 4 | 10e98fc862d89141512bdebae1231ef1a82105b0 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.47e-06 | 55 | 101 | 4 | a55d3edca2dd9ca7a703b2b3a5941b30b5f0a6df | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.47e-06 | 55 | 101 | 4 | bac333ea3914a49376105dd977a0b8493b0d2001 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.36e-05 | 150 | 101 | 5 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 166 | 101 | 5 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.06e-05 | 176 | 101 | 5 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 177 | 101 | 5 | c6812679aa6522d03bd29144e71c5fae6a92325e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 177 | 101 | 5 | ff97398d2adb83063b7c53a264bfae86ea7ea304 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 177 | 101 | 5 | 8f0873d348f37c823294b698043319b6608b678a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 182 | 101 | 5 | 9fc2f84bf70ad9a11c8a7326bd101e6f6cbcc33e | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.93e-05 | 182 | 101 | 5 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 6.09e-05 | 183 | 101 | 5 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 6.09e-05 | 183 | 101 | 5 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Aerocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.41e-05 | 185 | 101 | 5 | 7b3d30a54bec66ca6b0209c86448f4fff97ed75c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 6.91e-05 | 188 | 101 | 5 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.91e-05 | 188 | 101 | 5 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.09e-05 | 189 | 101 | 5 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.27e-05 | 190 | 101 | 5 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|Lymphoid / Condition, Lineage and Cell class | 7.45e-05 | 191 | 101 | 5 | bcdadf83cb9653f9cc2a281e7c1095fe8f79173c | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 192 | 101 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 7.64e-05 | 192 | 101 | 5 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-05 | 193 | 101 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | 15-Airway-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 8.02e-05 | 194 | 101 | 5 | ac0e48b0c09a7f57d30dff321b0c30a4c5e16ad9 | |
| ToppCell | 15-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 8.02e-05 | 194 | 101 | 5 | f3851337a2d17f4acef2cd812a766eb0b503748b | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.02e-05 | 194 | 101 | 5 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.02e-05 | 194 | 101 | 5 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.21e-05 | 195 | 101 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Neuronal-GABAergic_neurons|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.21e-05 | 195 | 101 | 5 | efdea22118d5be46c5abfe8e3fbe39503390665d | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.21e-05 | 195 | 101 | 5 | 31353269591c9eee84872838e91995d4a035da46 | |
| ToppCell | Tracheal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 197 | 101 | 5 | e91572edbe48d40269ee2cf7c858764cff6985ac | |
| ToppCell | Tracheal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 197 | 101 | 5 | 7e3f78a61089d1200cc6b0fa2034bf2998651694 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 8.83e-05 | 198 | 101 | 5 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 8.83e-05 | 198 | 101 | 5 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.25e-05 | 200 | 101 | 5 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | compound 31 | 1.10e-06 | 42 | 100 | 5 | CID005288687 | |
| Drug | tetradotoxin | CACNA1A CHRNA6 NPR1 HTR4 HTR6 GRIK2 CHRNB1 ADORA1 CACNA1G TACR3 ATP2A1 | 2.88e-06 | 428 | 100 | 11 | CID000020382 |
| Drug | quinuclidine | 1.01e-05 | 31 | 100 | 4 | CID000007527 | |
| Drug | guanethidine | 1.07e-05 | 113 | 100 | 6 | CID000003518 | |
| Drug | myo-inositol | CACNA1A CHRNA6 ERBB3 HTR4 CHRNB1 ADORA1 PROKR1 PTPN3 KAT2B MTOR CACNA1G TACR3 PLCG2 ATP2A1 | 1.22e-05 | 811 | 100 | 14 | CID000000892 |
| Drug | amsonine | 1.53e-05 | 181 | 100 | 7 | CID000002866 | |
| Drug | 5-formiminotetrahydrofolate | 1.91e-05 | 2 | 100 | 2 | CID000000530 | |
| Drug | 1,1,3-tribromopropane | 1.91e-05 | 2 | 100 | 2 | CID000134838 | |
| Drug | GF109203X | 1.96e-05 | 341 | 100 | 9 | CID000002396 | |
| Drug | atropine sulfate | 2.25e-05 | 347 | 100 | 9 | CID000003661 | |
| Drug | enzacamene | 2.27e-05 | 129 | 100 | 6 | ctd:C038939 | |
| Drug | prochloraz | 2.43e-05 | 268 | 100 | 8 | ctd:C045362 | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 6273_UP | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; PC3; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 3815_UP | |
| Drug | 2,3-dichlorooctafluorobutane | 2.89e-05 | 14 | 100 | 3 | CID000078982 | |
| Drug | phentolamine | 2.92e-05 | 200 | 100 | 7 | CID000005775 | |
| Drug | N-methyl-DL-aspartic acid | CACNA1A CHRNA6 NPR1 ERBB3 GRIK2 CHRNB1 ADORA1 PTPN3 MTOR DLG4 CACNA1G TACR3 | 3.03e-05 | 655 | 100 | 12 | CID000004376 |
| Drug | acetylcholine | 3.07e-05 | 361 | 100 | 9 | CID000000187 | |
| Drug | octylmethoxycinnamate | 3.46e-05 | 139 | 100 | 6 | ctd:C118580 | |
| Drug | C13932 | 3.52e-05 | 206 | 100 | 7 | CID000168297 | |
| Drug | carbachol | CACNA1A CHRNA6 NPR1 ERBB3 HTR4 CHRNB1 ADORA1 PTPN3 CACNA1G TACR3 PLCG2 ATP2A1 | 4.88e-05 | 688 | 100 | 12 | CID000002551 |
| Drug | AC1L1DXE | 5.27e-05 | 299 | 100 | 8 | CID000002548 | |
| Drug | thialysine | 5.35e-05 | 17 | 100 | 3 | CID000020048 | |
| Drug | NSC261137 | 6.39e-05 | 18 | 100 | 3 | CID000043055 | |
| Drug | butylparaben | 6.83e-05 | 157 | 100 | 6 | ctd:C038091 | |
| Drug | NSC683246 | 7.88e-05 | 234 | 100 | 7 | CID000005097 | |
| Drug | 4-phosphonomethylphenylalanine | 8.07e-05 | 52 | 100 | 4 | CID000126687 | |
| Disease | Neurodevelopmental Disorders | 1.58e-05 | 93 | 99 | 5 | C1535926 | |
| Disease | hypertension (implicated_via_orthology) | 7.33e-05 | 128 | 99 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | probable ATP-dependent RNA helicase DHX58 measurement | 1.11e-04 | 5 | 99 | 2 | EFO_0802901 | |
| Disease | Child Development Disorders, Specific | 1.26e-04 | 29 | 99 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.26e-04 | 29 | 99 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 1.39e-04 | 30 | 99 | 3 | C0008073 | |
| Disease | Schizophrenia | ERBB3 HTR4 HTR6 GRIK2 ERVW-1 SHANK3 ADORA1 MTOR DLG4 TACR3 TBP | 1.86e-04 | 883 | 99 | 11 | C0036341 |
| Disease | Mood Disorders | 2.62e-04 | 168 | 99 | 5 | C0525045 | |
| Disease | heart disease (implicated_via_orthology) | 2.84e-04 | 38 | 99 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Williams Syndrome | 3.08e-04 | 8 | 99 | 2 | C0175702 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 3.08e-04 | 8 | 99 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | mean arterial pressure, alcohol drinking | 3.38e-04 | 98 | 99 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | waist-hip ratio, metabolic syndrome | 3.95e-04 | 9 | 99 | 2 | EFO_0000195, EFO_0004343 | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 5.34e-04 | 47 | 99 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | Pain, Migratory | 6.03e-04 | 49 | 99 | 3 | C0751407 | |
| Disease | Suffering, Physical | 6.03e-04 | 49 | 99 | 3 | C0751408 | |
| Disease | Pain, Crushing | 6.03e-04 | 49 | 99 | 3 | C0458259 | |
| Disease | Pain, Splitting | 6.03e-04 | 49 | 99 | 3 | C0458257 | |
| Disease | Pain | 6.03e-04 | 49 | 99 | 3 | C0030193 | |
| Disease | Radiating pain | 6.03e-04 | 49 | 99 | 3 | C0234254 | |
| Disease | Pain, Burning | 6.03e-04 | 49 | 99 | 3 | C0234230 | |
| Disease | Ache | 6.03e-04 | 49 | 99 | 3 | C0234238 | |
| Disease | pulmonary function measurement, FEV/FEC ratio | 7.60e-04 | 53 | 99 | 3 | EFO_0003892, EFO_0004713 | |
| Disease | Intellectual Disability | 7.85e-04 | 447 | 99 | 7 | C3714756 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.14e-03 | 15 | 99 | 2 | C0496930 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 1.14e-03 | 15 | 99 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | Benign neoplasm of bladder | 1.14e-03 | 15 | 99 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.14e-03 | 15 | 99 | 2 | C0154091 | |
| Disease | Bipolar Disorder | 1.14e-03 | 477 | 99 | 7 | C0005586 | |
| Disease | Profound Mental Retardation | 1.26e-03 | 139 | 99 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.26e-03 | 139 | 99 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.26e-03 | 139 | 99 | 4 | C0917816 | |
| Disease | transitional cell carcinoma (is_marker_for) | 1.26e-03 | 63 | 99 | 3 | DOID:2671 (is_marker_for) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.30e-03 | 16 | 99 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | migraine without aura, susceptibility to, 4 | 1.30e-03 | 16 | 99 | 2 | MONDO_0011847 | |
| Disease | Carcinoma of bladder | 1.65e-03 | 18 | 99 | 2 | C0699885 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.08e-03 | 75 | 99 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | nephrosis (biomarker_via_orthology) | 2.46e-03 | 22 | 99 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | FEV/FEC ratio | ERBB3 HTR4 VPS13C GTF2IRD1 ARHGEF17 FCF1 AEBP2 ANTXR1 TRPM8 TRMT61B MMP15 | 2.75e-03 | 1228 | 99 | 11 | EFO_0004713 |
| Disease | nephrotic syndrome (implicated_via_orthology) | 2.93e-03 | 24 | 99 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | Ureteral obstruction | 2.93e-03 | 24 | 99 | 2 | C0041956 | |
| Disease | influenza A (H1N1) | 3.17e-03 | 87 | 99 | 3 | EFO_1001488 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRLFVFKLIPMLNPD | 281 | Q8NDL9 | |
| RVAYKRLLRMDLPVA | 1871 | O00555 | |
| RLMQEYRLRELFKPS | 221 | Q96CN4 | |
| TRMARDPPRYLVIKR | 966 | P21860 | |
| SDPYVRMYLLPDKRR | 821 | A0FGR8 | |
| PLRYKLRMTPLRALA | 131 | P50406 | |
| LLLDPNIYRTMPQKR | 486 | Q6ZN18 | |
| LRKGYDRVSVMRPQP | 461 | Q9H6X2 | |
| RPIYPNRREREAMIL | 76 | Q0P641 | |
| IPLRYKMVVTPRRAA | 111 | P30542 | |
| ALMRPGRIDRIIYVP | 781 | Q8NB90 | |
| LYLRLKRPKPERDLM | 356 | P11230 | |
| RVLPIMFPALYRNSK | 441 | Q14738 | |
| ILRMLDYDPKTRIQP | 456 | Q13627 | |
| SLPSVTRPRLRVKMY | 746 | Q96K78 | |
| LLRTMPRKGRVIYIC | 231 | P16066 | |
| RRKFLLLGMRPFIPD | 461 | Q9NUG4 | |
| LILYVDPLPMIFKLR | 946 | O14983 | |
| RARRPDMALYVPKAR | 11 | Q7Z5L2 | |
| MPLVRYRKVVILGYR | 1 | Q8TAI7 | |
| MVTRFLGPRYRELVK | 1 | O14957 | |
| FLLKPMQRITRYPLL | 1346 | Q9NZM3 | |
| RVRGYLEMRLPDIPL | 641 | Q75QN2 | |
| FRVYRMLPLSERPSK | 106 | P14316 | |
| LPRMPKEYIARLVFD | 531 | Q92830 | |
| LPIYPLDIVRKMRDQ | 866 | P26045 | |
| MIKPVQRIPRYELLV | 1206 | Q96PE2 | |
| LQPYLRLMRLDKPIG | 71 | Q96H96 | |
| RRYFMKRLLIPLPDS | 641 | Q5HY92 | |
| MTEILLERKYRPIPE | 216 | Q5VUJ9 | |
| FMLETLRYVKAVRPR | 186 | Q12891 | |
| MLVDPSRQPYRVKVI | 331 | Q9H2X6 | |
| LPRMPKEYITRLVFD | 526 | Q92831 | |
| IQVLRPMIKDFRRYL | 286 | Q69YI7 | |
| DVRRPLYKMEQIPLS | 181 | Q9C0K3 | |
| RLRMEPGYPKSILRD | 541 | P51511 | |
| LRPLVKTMAYRELRP | 241 | A0A0J9YX94 | |
| RSVALIFPLPFMLKR | 156 | Q8NGK0 | |
| LEPVQRIPRYEMLLK | 346 | Q96M96 | |
| RRPSDKYRLIVLMGP | 421 | Q96JB8 | |
| VHRLPRPLKQRMLEY | 501 | Q9UQ05 | |
| KRQVPYLRVTVMPLL | 66 | Q8IWV1 | |
| LIYEEVARMPPFRRK | 361 | Q14168 | |
| RKMVLYTLRAPRSPK | 91 | P16860 | |
| RQREYLLDMIPPRSI | 571 | Q8WXI9 | |
| PLLPMRYRKLRVFSG | 156 | Q9UL42 | |
| YRKMRLRYPVTPELL | 726 | P16885 | |
| MLIIPFTLLTKRLPY | 156 | Q8NGI0 | |
| FKVLLSPDYLPAMRR | 631 | Q7Z6Z7 | |
| PIVRKEIEYRMARGP | 316 | Q92729 | |
| PRKYRLGMLEERLVP | 231 | Q58A45 | |
| PVIYVFMIRKFRRSL | 306 | Q9H1Y3 | |
| YRPRKNPLFIMDLVL | 651 | Q9P2D7 | |
| IRRLPMFYTINLIIP | 236 | Q15825 | |
| YAPDLMKRLRFALIP | 256 | Q9P2G3 | |
| MKRLRFALIPAPELV | 261 | Q9P2G3 | |
| NLRPMIERKIPELYK | 2056 | Q8NF50 | |
| FRLMRVLKLVRFLPA | 836 | O43497 | |
| YNVARLIPRLAKDRM | 936 | Q9UFH2 | |
| YQIPRRIFIQLMKRF | 331 | Q5THR3 | |
| RRIRKIPGVPIMYIS | 166 | Q9Y324 | |
| RGRIYLEPPTMRKKR | 86 | Q9H4A5 | |
| PLVYRNKMTPLRIAL | 126 | Q13639 | |
| GSIVRLYVMRRKPPA | 141 | P78352 | |
| PTTAYMLRLKQPRAR | 306 | Q96NU7 | |
| MRYLALMVSRPVLRL | 336 | Q6ZN54 | |
| LERLLTRYQEMPEPK | 371 | Q92636 | |
| YFLSRRIPLPRRTKM | 341 | Q7KZN9 | |
| MKIIFPILSNPVFRR | 1 | Q13002 | |
| GLLLRRMELKPLRVY | 2231 | Q9BYK8 | |
| RRPAEYDPKALMAIL | 176 | Q9UHL9 | |
| YGRLYRVVEPKRIRM | 3206 | Q9P225 | |
| MRRLIPPFREASAKL | 391 | O95954 | |
| PKQRRSIIRDRGPMY | 81 | P51608 | |
| RLIRPYMEPILKALI | 766 | P42345 | |
| YPPLLRAMIIAERQK | 166 | P82930 | |
| LFPRLTADMRRFRKP | 3201 | Q5T011 | |
| MQSKTKIYRRPLDRP | 491 | Q9UQF0 | |
| RIKLYMRRLLCLPSP | 441 | Q8N4U5 | |
| MAEARKRRELLPLIY | 1 | Q13428 | |
| YRLLAPSRDIRMVPE | 576 | Q9HCE1 | |
| LPIYTELCRPSKRRM | 276 | Q8WUX1 | |
| FPRRVLPKELGQRML | 326 | Q5JR12 | |
| HPRMRRYIKNPRIVL | 226 | P49368 | |
| YRRRFPQKIMTPADL | 61 | O75925 | |
| RQPIELLSMKRYELP | 76 | O75934 | |
| VDRYMAIIDPLKPRL | 181 | P29371 | |
| DRYLAIVHPLRPRMK | 161 | Q8TCW9 | |
| LMRYPARAIKVLLAG | 1536 | Q9BXT8 | |
| LRRPALEDYVVLMKR | 211 | Q9BVS5 | |
| PYPERQKRARSMIIL | 881 | Q9BYB0 | |
| IRYREPRRMLAMPID | 66 | Q7Z7F7 | |
| ELFPGLIYRMIKPRI | 286 | P20226 | |
| LIYRMIKPRIVLLIF | 291 | P20226 | |
| VRIAYDRPRGRPMSK | 981 | Q8IX01 | |
| PRFSLKQGMIPRRYV | 36 | Q6ZNM6 | |
| YRLRPMLRVFVKPLV | 886 | Q9HAV4 | |
| MRLPIRSPIKRDFLS | 3171 | Q709C8 | |
| MNVIYPLAVPKGRRL | 1 | Q9H0C1 | |
| EKFVRRVMKPLLYIP | 206 | Q6PKC3 | |
| PARRIAMAPLLEYER | 6 | Q92889 | |
| ALKPRMRKIFSRLIY | 156 | Q7Z2W7 | |
| PPDIYRRKVLLMYPI | 226 | Q96BW1 | |
| PGLIYRMVKPRIVLL | 326 | Q6SJ96 | |
| SKPSFMPRLYINRRL | 466 | Q5T447 |